Diagnostic criteria for dementia in clinical trials: Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines

Piero Antuono, Rachelle Doody, Sid Gilman, Jacob Huff, Philip Scheltens, Keiji Ueda, Zaven S. Khachaturian

Research output: Contribution to journalArticlepeer-review

Abstract

Some of the issues associated with standardizing the diagnosis of dementia in clinical trials are outlined. Deliberations of the Working Group on Diagnostic Criteria and their recommendations for future actions needed to develop a consensus are described.

Original languageEnglish (US)
Pages (from-to)22-25
Number of pages4
JournalAlzheimer Disease and Associated Disorders
Volume11
Issue numberSUPPL. 3
StatePublished - 1997
Externally publishedYes

Keywords

  • Alzheimer disease
  • Clinical Trials
  • Criteria
  • Diagnosis
  • International standardization

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Diagnostic criteria for dementia in clinical trials: Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines'. Together they form a unique fingerprint.

Cite this